What is the protocol for beta (beta blocker) reversal in cases of overdose or toxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Beta Blocker Overdose Management Protocol

High-dose insulin therapy is the first-line antidote for beta blocker overdose, with glucagon and vasopressors recommended for refractory cases. 1

Initial Assessment and Stabilization

  • Recognize clinical presentation: Bradycardia, hypotension, cardiogenic shock, heart block, and altered mental status
  • Secure airway and breathing: Provide supplemental oxygen and ventilatory support as needed
  • Establish IV access: Preferably central venous access for medication administration

Pharmacological Management Algorithm

First-Line Treatment: High-Dose Insulin Therapy

  • Initial bolus: 1 U/kg regular insulin IV 1, 2
  • Maintenance: 1-10 U/kg/hour continuous infusion 1, 2
  • Concurrent dextrose: Administer 0.5 g/kg dextrose bolus followed by continuous infusion
  • Monitoring: Check glucose every 15-30 minutes initially, then hourly; maintain 100-250 mg/dL
  • Potassium monitoring: Expect moderate hypokalemia; don't aggressively replace unless <2.5 mEq/L

Second-Line Treatment: Glucagon

  • Initial dose: 2-10 mg IV bolus over 3-5 minutes 1, 3
  • Maintenance: 1-15 mg/hour infusion 1, 3
  • Caution: Protect airway before administration as vomiting is common
  • Availability: Ensure adequate supply as large quantities may be needed

Vasopressor Support (Concurrent with Above)

  • Initial vasopressors: Epinephrine and norepinephrine are more effective than dopamine 1
  • Dosing: Standard vasopressor dosing, titrated to effect
  • Indication: For immediate blood pressure support while other therapies take effect

Additional Interventions for Refractory Cases

  • Calcium administration:

    • Calcium chloride: 20 mg/kg (0.2 mL/kg of 10% solution) IV over 5-10 minutes 1
    • If beneficial, continue infusion at 20-50 mg/kg/hour 1
    • Preferably administer through central venous access
  • Atropine for bradycardia:

    • 0.5-1.0 mg IV every 3-5 minutes up to 3 mg (adult) 1
    • 0.02 mg/kg (pediatric) 1

Refractory Shock Management

  • Consider VA-ECMO: For life-threatening beta blocker poisoning with cardiogenic shock refractory to pharmacological interventions 1
  • Hemodialysis: May be reasonable for life-threatening atenolol or sotalol poisoning 1

Important Considerations and Pitfalls

  • Avoid Class IA, IC, or III antiarrhythmics: These may exacerbate cardiac toxicity 1
  • Intravenous lipid emulsion therapy: Not likely to be beneficial for beta blocker poisoning 1
  • Treatment duration: Continue therapy until clinical improvement and drug elimination (may require 24+ hours depending on the specific beta blocker)
  • Electrical pacing: May be reasonable for refractory bradycardia but often ineffective due to myocardial depression 1
  • Glucagon limitations: Requires large quantities which may not be readily available; vomiting is a common side effect 1, 3

Monitoring During Treatment

  • Continuous cardiac monitoring: ECG, heart rate, blood pressure
  • Frequent laboratory assessment: Glucose, potassium, calcium, arterial blood gases
  • End-organ perfusion: Urine output, mental status, peripheral perfusion

This protocol provides a systematic approach to managing beta blocker overdose, focusing on interventions that improve morbidity and mortality outcomes through targeted pharmacological therapy and supportive care.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Beta Blocker Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Glucagon therapy for beta-blocker overdose.

Drug intelligence & clinical pharmacy, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.